tradingkey.logo

Accelerate Diagnostics Inc

AXDX

0.034USD

-0.054-61.36%
Market hours ETQuotes delayed by 15 min
856.34KMarket Cap
LossP/E TTM

Accelerate Diagnostics Inc

0.034

-0.054-61.36%
More Details of Accelerate Diagnostics Inc Company
Accelerate Diagnostics, Inc. is in vitro diagnostics company engaged in providing solutions for the global challenges of antibiotic resistance and sepsis. Its Accelerate Pheno system and Accelerate PhenoTest BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the optimal antibiotic therapy for infections. The Accelerate PhenoTest BC Kit, which is the test kit for the system, is indicated as an aid, in conjunction with other clinical and laboratory findings, in the diagnosis of bacteremia and fungemia, both life-threatening conditions with high morbidity and mortality risk. The device provides identification (ID) results followed by antibiotic susceptibility testing (AST) for certain pathogenic bacteria commonly associated with or causing bacteremia. Its other products include Accelerate Pheno system and BC kit, Accelerate Arc system and BC Kit (Accelerate Arc Products), and Accelerate Wave system.
Company Info
Ticker SymbolAXDX
Company nameAccelerate Diagnostics Inc
IPO dateOct 27, 1993
Founded at2012
CEOMr. John (Jack) Phillips
Number of employees107
Security typeOrdinary Share
Fiscal year-endOct 27
Address3950 S Country Club Rd Ste 470 Bldg 3-307
CityDENVER
Stock exchangeBolsa Mexicana de Valores S.A. de C.V.
CountryUnited States of America
Postal code80203
Phone13038638088
Websitehttps://acceleratediagnostics.com/
Ticker SymbolAXDX
IPO dateOct 27, 1993
Founded at2012
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Jack W. Schuler
Mr. Jack W. Schuler
Independent Director
Independent Director
8.33M
--
Mr. John Patience
Mr. John Patience
Independent Director
Independent Director
897.68K
+28.67%
Mr. Hany Massarany
Mr. Hany Massarany
Independent Chairman of the Board
Independent Chairman of the Board
39.89K
--
Ms. Louise L. Francesconi
Ms. Louise L. Francesconi
Independent Director
Independent Director
33.56K
--
Ms. Jennifer Regan
Ms. Jennifer Regan
Independent Director
Independent Director
12.63K
--
Dr. Lawrence Michael (Larry) Mertz, Ph.D.
Dr. Lawrence Michael (Larry) Mertz, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Wayne C. Burris
Mr. Wayne C. Burris
Independent Director
Independent Director
--
--
Mr. Paul Shalhoub
Mr. Paul Shalhoub
Independent Director
Independent Director
--
--
Mr. Gilbert Nathan
Mr. Gilbert Nathan
Independent Director
Independent Director
--
--
Mr. Mark Black
Mr. Mark Black
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Jack W. Schuler
Mr. Jack W. Schuler
Independent Director
Independent Director
8.33M
--
Mr. John Patience
Mr. John Patience
Independent Director
Independent Director
897.68K
+28.67%
Mr. Hany Massarany
Mr. Hany Massarany
Independent Chairman of the Board
Independent Chairman of the Board
39.89K
--
Ms. Louise L. Francesconi
Ms. Louise L. Francesconi
Independent Director
Independent Director
33.56K
--
Ms. Jennifer Regan
Ms. Jennifer Regan
Independent Director
Independent Director
12.63K
--
Dr. Lawrence Michael (Larry) Mertz, Ph.D.
Dr. Lawrence Michael (Larry) Mertz, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Jun 30
Currency: USDUpdated: Mon, Jun 30
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Products
10.22M
87.34%
Services
1.48M
12.66%
By RegionUSD
Name
Revenue
Proportion
Domestic(United States)
10.40M
88.90%
Foreign
1.30M
11.10%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Products
10.22M
87.34%
Services
1.48M
12.66%
Shareholding Stats
Updated: Sat, May 17
Updated: Sat, May 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Schuler (Jack W)
33.04%
Armistice Capital LLC
7.45%
Patience (John)
3.56%
Griffin Asset Management, Inc.
3.38%
The Vanguard Group, Inc.
1.90%
Other
50.66%
Shareholders
Shareholders
Proportion
Schuler (Jack W)
33.04%
Armistice Capital LLC
7.45%
Patience (John)
3.56%
Griffin Asset Management, Inc.
3.38%
The Vanguard Group, Inc.
1.90%
Other
50.66%
Shareholder Types
Shareholders
Proportion
Individual Investor
38.31%
Hedge Fund
7.94%
Investment Advisor/Hedge Fund
6.80%
Investment Advisor
2.78%
Research Firm
0.06%
Other
44.11%
Institutional Shareholding
Updated: 16 hours ago
Updated: 16 hours ago
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
105
14.09M
55.89%
-384.07K
2025Q1
118
13.85M
55.65%
-4.87M
2024Q4
130
14.16M
56.68%
-4.68M
2024Q3
138
14.45M
59.92%
-3.94M
2024Q2
148
14.03M
59.45%
-4.73M
2024Q1
212
12.64M
57.77%
-1.32M
2023Q4
221
9.17M
25.59%
-847.52K
2023Q3
236
9.25M
26.48%
-524.51K
2023Q2
242
9.11M
170.35%
+3.03M
2023Q1
248
5.18M
51.90%
-755.19K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Schuler (Jack W)
8.33M
33.04%
--
--
Apr 15, 2025
Armistice Capital LLC
1.88M
7.45%
-198.77K
-9.57%
Mar 31, 2025
Patience (John)
897.68K
3.56%
+200.00K
+28.67%
Apr 15, 2025
Griffin Asset Management, Inc.
853.04K
3.38%
-150.54K
-15.00%
Mar 31, 2025
The Vanguard Group, Inc.
478.09K
1.9%
--
--
Mar 31, 2025
Birchview Capital, LP
325.24K
1.29%
--
--
Mar 31, 2025
Phillips (Jack)
191.37K
0.76%
+27.94K
+17.10%
Apr 15, 2025
Lido Advisors, LLC
163.16K
0.65%
+163.16K
--
Mar 31, 2025
Geode Capital Management, L.L.C.
142.52K
0.57%
+6.79K
+5.00%
Mar 31, 2025
Cannell & Spears LLC
114.52K
0.45%
--
--
Mar 31, 2025
View more
Related ETFs
Updated: Fri, Jun 6
Updated: Fri, Jun 6
Name
Proportion
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jul 10, 2023
Merger
10<1
Jul 10, 2023
Merger
10<1
Jul 10, 2023
Merger
10<1
Jul 10, 2023
Merger
10<1
Date
Type
Ratio
Jul 10, 2023
Merger
10<1
Jul 10, 2023
Merger
10<1
Jul 10, 2023
Merger
10<1
Jul 10, 2023
Merger
10<1
KeyAI